Upregulation of programmed cell death ligand 1 promotes resistance response in non‐small‐cell lung cancer patients treated with neo‐adjuvant chemotherapyPanpan Zhang(Sun Yat-sen University), Yue Yang(Northwestern University)Cancer ScienceSeptember 1, 201610.1111/cas.13072Cited by 184SaveCiteExport RISWatch citationsRelated PapersBPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1|Theranostics|2018|56Efficacy and safety of HBM4003 combined with toripalimab in refractory neuroendocrine neoplasms: a multicenter, phase II study|EClinicalMedicine|2025|3